To uncover OPA1’s pivotal role in mediating PFKFB3’s protection against DCM, we utilized a cardiomyocyte-specific viral shRNA targeting OPA1, driven by the cTnT promoter (Fig. 5A). Here, PFKFB3 is linked to familial dilated cardiomyopathy.